Zhejiang Cheng Yi Pharmaceutical Hits Day Low Amid Price Pressure at CNY 7.18

Zhejiang Cheng Yi Pharmaceutical Co., Ltd. experienced a notable decline today, with the stock dropping by 7.63% and reaching an intraday low of CNY 7.18. This performance contrasts sharply with the China Shanghai Composite, which saw a modest gain of 0.85% on the same day. Over the past week, Zhejiang Cheng Yi's stock has decreased by 0.68%, while its performance over the last month shows a decline of 4.65%. Year-to-date, the stock has lost 3.2%, and its one-year performance reflects a significant drop of 17.1%, compared to a 7.41% increase in the broader market index. Despite these short-term fluctuations, the company has reported positive results for the last three consecutive quarters, with operating cash flow reaching a high of CNY 308.94 million. The return on capital employed (ROCE) stands at 17.64%, and the company maintains a low debt-equity ratio of -6.68%. With a return on equity (ROE) of 18.55% and a price-to-book ratio of 3.30, Zhejiang Cheng Yi continues to demonstrate a solid valuation profile within the pharmaceuticals and biotechnology sector.